• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种包含三种一线抗结核抗生素的新型可吸入干粉制剂。

A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.

作者信息

Chan John Gar Yan, Chan Hak-Kim, Prestidge Clive A, Denman John A, Young Paul M, Traini Daniela

机构信息

Faculty of Pharmacy, The University of Sydney, Sydney, NSW 2006, Australia.

Ian Wark Research Institute, The University of South Australia, Mawson Lakes, Australia.

出版信息

Eur J Pharm Biopharm. 2013 Feb;83(2):285-92. doi: 10.1016/j.ejpb.2012.08.007. Epub 2012 Sep 13.

DOI:10.1016/j.ejpb.2012.08.007
PMID:22982733
Abstract

Treatment for tuberculosis (TB) using the standard oral antibiotic regimen is effective but inefficient, requiring high drug dosing and lengthy treatment times. Three concurrent first-line antibiotics recommended by the World Health Organization (WHO) guidelines are pyrazinamide, rifampicin and isoniazid. Combining these antibiotics in a novel formulation for dry powder inhalation (DPI) may facilitate rapid and efficient resolution of local and systemic infection. However, spray-dried individually, these antibiotics were found to be physically unstable. A solution of the three antibiotics, at the WHO-recommended ratio, was spray-dried. The collected powder was assessed by a series of in vitro methods to investigate aerosol performance, particle physico-chemical characteristics and dissolution profile. Particles obtained were spherical with a surface composed primarily of rifampicin, as identified by TOF-SIMS. A mass median aerodynamic diameter of 3.5 ± 0.1 μm and fine particle fraction (<5 μm) of 45 ± 3% indicated excellent aerosol performance. The combination powder was differentiated by the presence of rifampicin dihydrate and the delta polymorph of pyrazinamide. Quantitative analysis indicated individual particles contained the three antibiotics at the expected proportions (400:150:75 w/w). This excipient-free triple antibiotic DPI formulation could be used as a significant enhanced treatment for TB.

摘要

使用标准口服抗生素方案治疗结核病(TB)是有效的,但效率低下,需要高剂量用药和较长的治疗时间。世界卫生组织(WHO)指南推荐的三种一线联合抗生素为吡嗪酰胺、利福平和异烟肼。将这些抗生素组合成一种新型的干粉吸入剂(DPI)剂型可能有助于快速有效地消除局部和全身感染。然而,单独喷雾干燥时,发现这些抗生素在物理上不稳定。将三种抗生素按WHO推荐的比例制成溶液后进行喷雾干燥。通过一系列体外方法对收集的粉末进行评估,以研究气溶胶性能、颗粒物理化学特性和溶解曲线。通过飞行时间二次离子质谱(TOF-SIMS)鉴定,所得颗粒呈球形,表面主要由利福平组成。质量中值空气动力学直径为3.5±0.1μm,细颗粒分数(<5μm)为45±3%,表明气溶胶性能优异。该组合粉末的特征在于含有二水合利福平和吡嗪酰胺的δ多晶型物。定量分析表明,单个颗粒中三种抗生素的比例符合预期(400:150:75 w/w)。这种无赋形剂的三联抗生素DPI剂型可作为一种显著增强的结核病治疗方法。

相似文献

1
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.一种包含三种一线抗结核抗生素的新型可吸入干粉制剂。
Eur J Pharm Biopharm. 2013 Feb;83(2):285-92. doi: 10.1016/j.ejpb.2012.08.007. Epub 2012 Sep 13.
2
Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.贝达喹啉三联吸入用粉末治疗耐药结核病。
Int J Pharm. 2019 Oct 30;570:118689. doi: 10.1016/j.ijpharm.2019.118689. Epub 2019 Sep 9.
3
L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.L-亮氨酸作为一种辅料对高吸湿性喷雾干燥粉末体外雾化性能的防潮作用。
Eur J Pharm Biopharm. 2016 May;102:132-41. doi: 10.1016/j.ejpb.2016.02.010. Epub 2016 Mar 9.
4
Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.基于磷脂的吡嗪酰胺喷雾干燥吸入粉末治疗结核病。
Int J Pharm. 2016 Jun 15;506(1-2):174-83. doi: 10.1016/j.ijpharm.2016.04.038. Epub 2016 Apr 28.
5
Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.保护疏水性氨基酸,防止高吸湿性喷雾干燥粉末的雾化性能因水分引起的劣化。
Eur J Pharm Biopharm. 2017 Oct;119:224-234. doi: 10.1016/j.ejpb.2017.06.023. Epub 2017 Jun 24.
6
Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.靶向结核病的D-LAK抗菌肽可吸入喷雾干燥制剂。
Int J Pharm. 2015 Aug 1;491(1-2):367-74. doi: 10.1016/j.ijpharm.2015.07.001. Epub 2015 Jul 4.
7
Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.以甘露醇为可吸入微粒/纳米颗粒的先进共喷雾干燥抗生素作为干粉吸入剂用于靶向肺部给药的设计、表征和气溶胶分散性能建模
J Pharm Sci. 2014 Sep;103(9):2937-2949. doi: 10.1002/jps.23955. Epub 2014 Apr 16.
8
Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.硬脂酸镁对干粉吸入制剂气溶胶性能的改性机制研究。
J Pharm Sci. 2018 Apr;107(4):984-998. doi: 10.1016/j.xphs.2017.12.006. Epub 2017 Dec 14.
9
Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.具有高效气溶胶化特性的黏菌素粉剂用于呼吸道感染:制备与体外评价。
J Pharm Sci. 2013 Oct;102(10):3736-47. doi: 10.1002/jps.23685. Epub 2013 Jul 31.
10
Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.使用多呼吸Orbital®干粉吸入器装置调节气雾剂性能:通过改变药盘孔口几何形状控制递送参数和气雾剂性能。
J Pharm Sci. 2015 Jul;104(7):2169-76. doi: 10.1002/jps.24458. Epub 2015 Apr 30.

引用本文的文献

1
Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis.载 D-LAK 抗菌肽和卷曲霉素的联合递药吸入粉体制剂用于治疗耐药结核病。
Pharm Res. 2023 May;40(5):1073-1086. doi: 10.1007/s11095-023-03488-y. Epub 2023 Mar 3.
2
Dissolution and Absorption of Inhaled Drug Particles in the Lungs.吸入药物颗粒在肺部的溶解与吸收
Pharmaceutics. 2022 Nov 30;14(12):2667. doi: 10.3390/pharmaceutics14122667.
3
Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model.
雾化异烟肼对小鼠模型中结核病的比活性研究。
Antibiotics (Basel). 2022 Nov 1;11(11):1527. doi: 10.3390/antibiotics11111527.
4
Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.靶向巨噬细胞治疗结核病的药物递送最新进展
Adv Ther (Weinh). 2022 Jun;5(6). doi: 10.1002/adtp.202100193. Epub 2022 Mar 9.
5
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation.吸入用利福平制剂及临床前研究综述及其临床转化。
Drug Deliv Transl Res. 2023 May;13(5):1246-1271. doi: 10.1007/s13346-022-01238-y. Epub 2022 Sep 21.
6
Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.多粘菌素共喷雾干燥提高吸入性妥布霉素粉末制剂的气溶胶化稳定性。
Pharm Res. 2022 Nov;39(11):2781-2799. doi: 10.1007/s11095-022-03344-5. Epub 2022 Aug 2.
7
Spray freeze drying to solidify Nanosuspension of Cefixime into inhalable microparticles.喷雾冷冻干燥将头孢克肟纳米混悬液固化为可吸入的微颗粒。
Daru. 2022 Jun;30(1):17-27. doi: 10.1007/s40199-021-00426-4. Epub 2022 Jan 8.
8
Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.含组合药物纳米颗粒的喷雾冷冻干燥可吸入复合微粒用于潜在治疗铜绿假单胞菌引起的肺部感染。
Int J Pharm. 2021 Dec 15;610:121160. doi: 10.1016/j.ijpharm.2021.121160. Epub 2021 Oct 6.
9
Administration of dry powders during respiratory supports.在呼吸支持期间给予干粉剂。
Ann Transl Med. 2021 Apr;9(7):596. doi: 10.21037/atm-20-3946.
10
Development and Evaluation of a Reconstitutable Dry Suspension Containing Isoniazid for Flexible Pediatric Dosing.一种用于灵活儿科给药的含异烟肼可重构干混悬剂的研发与评价
Pharmaceutics. 2020 Mar 23;12(3):286. doi: 10.3390/pharmaceutics12030286.